287 related articles for article (PubMed ID: 16959934)
21. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet.
Parkman HP; Carlson MR; Gonyer D
Neurogastroenterol Motil; 2014 Apr; 26(4):521-8. PubMed ID: 24372829
[TBL] [Abstract][Full Text] [Related]
22. Use of mirtazapine in functional vomiting.
Bondade S; Basavaraju V; Singh N
Aust N Z J Psychiatry; 2016 Jan; 50(1):102-3. PubMed ID: 26320233
[No Abstract] [Full Text] [Related]
23. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
Soykan I; Sarosiek I; McCallum RW
Am J Gastroenterol; 1997 Jun; 92(6):976-80. PubMed ID: 9177513
[TBL] [Abstract][Full Text] [Related]
24. Resolution of severe gastroparesis induced by parasympathetic surge following facial trauma: a case report.
Haseeb-Ul-Rasool M; Elhawary A; Saha U; Sethi A; Swaminathan G; Abosheaishaa H
J Med Case Rep; 2024 May; 18(1):248. PubMed ID: 38750592
[TBL] [Abstract][Full Text] [Related]
25. Symptomatic management for gastroparesis: antiemetics, analgesics, and symptom modulators.
Hasler WL
Gastroenterol Clin North Am; 2015 Mar; 44(1):113-26. PubMed ID: 25667027
[TBL] [Abstract][Full Text] [Related]
26. Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
Parkman HP; Carlson MR; Gonyer D
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1256-1263.e1. PubMed ID: 25576687
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
Heckert J; Parkman HP
Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
[TBL] [Abstract][Full Text] [Related]
28. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
Patterson D; Abell T; Rothstein R; Koch K; Barnett J
Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
[TBL] [Abstract][Full Text] [Related]
29. Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data.
Wo JM; Ejskjaer N; Hellström PM; Malik RA; Pezzullo JC; Shaughnessy L; Charlton P; Kosutic G; McCallum RW
Aliment Pharmacol Ther; 2011 Mar; 33(6):679-88. PubMed ID: 21214610
[TBL] [Abstract][Full Text] [Related]
30. Gastric residual volume in children: a study comparing efficiency of erythromycin and metoclopramide as prokinetic agents.
Zatman TF; Hall JE; Harmer M
Br J Anaesth; 2001 Jun; 86(6):869-71. PubMed ID: 11573597
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of severely delayed gastric emptying].
Samsom M; Gooszen HG
Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1945-8. PubMed ID: 11048557
[TBL] [Abstract][Full Text] [Related]
32. Safety of treatment for gastroparesis.
Sarosiek I; Bashashati M; McCallum RW
Expert Opin Drug Saf; 2016 Jul; 15(7):937-45. PubMed ID: 27031006
[TBL] [Abstract][Full Text] [Related]
33. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
[TBL] [Abstract][Full Text] [Related]
34. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
[TBL] [Abstract][Full Text] [Related]
35. Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology.
Thompson DS
Psychosomatics; 2000; 41(4):356-9. PubMed ID: 10906359
[No Abstract] [Full Text] [Related]
36. Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort.
Schey R; Saadi M; Midani D; Roberts AC; Parupalli R; Parkman HP
Dig Dis Sci; 2016 Dec; 61(12):3545-3551. PubMed ID: 27530760
[TBL] [Abstract][Full Text] [Related]
37. Idiopathic gastroparesis: case report and literature review of diagnostic and treatment modalities.
Chaudrey KH; Patel R; Alam M; Avashia K; Khan SI; Titarenko N; Ihsan M
Am J Ther; 2013 Jan; 20(1):111-7. PubMed ID: 21799394
[TBL] [Abstract][Full Text] [Related]
38. Gastroparesis: New insights into an old disease.
Usai-Satta P; Bellini M; Morelli O; Geri F; Lai M; Bassotti G
World J Gastroenterol; 2020 May; 26(19):2333-2348. PubMed ID: 32476797
[TBL] [Abstract][Full Text] [Related]
39. The use of tegaserod in critically ill patients with impaired gastric motility.
Banh HL; MacLean C; Topp T; Hall R
Clin Pharmacol Ther; 2005 Jun; 77(6):583-6. PubMed ID: 15961989
[TBL] [Abstract][Full Text] [Related]
40. Gastroparesis in Adolescent Patient with Type 1 Diabetes: Severe Presentation of a Rare Pediatric Complication.
Lombardo F; Bombaci B; Costa S; Valenzise M; Giannitto N; Cardile D; Baldari S; Salzano G; Passanisi S
J Clin Res Pediatr Endocrinol; 2024 Mar; 16(1):111-115. PubMed ID: 36047486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
